Coxsackie IgG Virus Control Serum BC134G

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Coxsackie IgG Virus Control Serum
Applications: ELISA
IgG control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC134G Categories: control serum, Virion/Serion kits Tags: Coxsackievirus, ELISA control serum, IgG

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Coxsackie Virus reactive IgG
species reactivity	Coxsackievirus (hand, foot, and mouth disease)
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Coxsackie IgG Virus Control Serum BC134G

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Coxsackievirus Antigen (BA134VS01) Cocksackie IgA Virus Control Serum (BC134A) Cocksackie IgG Virus Control Serum (BC134G) Cocksackie IgM Virus Control Serum (BC134M) Cocksackievirus IgA ELISA Kit (ESR134A) Cocksackievirus IgG ELISA Kit (ESR134G) Cocksackievirus IgM ELISA Kit (ESR134M)

target relevance

human antibody anti-Coxsackievirus

Coxsackievirus

Description
Virus that causes hand, foot and mouth disease, herpangina, myocarditis, and other enteroviral infections

Structure
Coxsackieviruses are non-enveloped, positive-sense, single-stranded RNA viruses belonging to the genus Enterovirus within the family Picornaviridae. The viruses possess an icosahedral capsid that protects the viral RNA genome and contributes to environmental stability. Coxsackieviruses are divided into Group A and Group B based on their pathogenic properties and biological characteristics. These viruses are transmitted primarily through the fecal-oral route, respiratory secretions, and direct contact with contaminated surfaces. Following infection, viral replication typically occurs in the gastrointestinal and respiratory tracts before dissemination to other tissues. Coxsackieviruses are distributed worldwide and are a common cause of childhood and adult infections, with outbreaks occurring periodically in communities, schools, and daycare settings.

Diagnosis
The diagnosis of Coxsackievirus infection is performed through molecular, virological, and serological methods. Reverse transcription polymerase chain reaction (RT-PCR) is the preferred diagnostic technique for detecting viral RNA in throat swabs, stool samples, cerebrospinal fluid, blood, and tissue specimens due to its high sensitivity and specificity. Viral culture may be used in specialized laboratories but has largely been replaced by molecular methods. Serological assays, including ELISA-based tests, can detect virus-specific antibodies and may be useful in epidemiological investigations or retrospective diagnosis. Clinical presentation and epidemiological context often play an important role in guiding diagnostic testing.

Symptoms
Coxsackievirus infections produce a wide spectrum of clinical manifestations ranging from mild febrile illness to severe systemic disease. Group A coxsackieviruses commonly cause hand, foot and mouth disease and herpangina, characterized by fever, sore throat, painful oral ulcers, and vesicular lesions on the hands and feet. Group B coxsackieviruses are frequently associated with pleurodynia, myocarditis, pericarditis, and viral meningitis. Additional symptoms may include headache, fatigue, muscle aches, abdominal pain, nausea, vomiting, and rash. While most infections are self-limiting and resolve without complications, severe disease can occur in neonates, immunocompromised individuals, and patients with cardiac involvement, potentially resulting in life-threatening complications.

Data

FAQ & Publications

Frequently Asked Questions

What applications is the Coxsackie IgG Virus Control Serum BC134G suitable for?

This serum is designed for use as an IgG control in ELISA applications, specifically compatible with SERION ELISA classic and SERION ELISA antigen assays.

How should the Coxsackie IgG Virus Control Serum BC134G be stored to maintain its stability?

The serum should be stored refrigerated at 2-8°C to preserve its activity and ensure reliable performance.

What is the target specificity of the Coxsackie IgG Virus Control Serum BC134G?

This control serum targets Coxsackie virus reactive IgG antibodies, relevant for detecting immune response to Coxsackievirus infections.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC134G protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Coxsackie IgG Virus Control Serum BC134G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Cytomegalovirus IgG Control Serum BC109G

Brucella IgG Control Serum BC116G

Echovirus IgG Control Serum BC135G

Borrelia burgdorferi IgG Control Serum BC121G

Echinococcus IgG Control Serum BC107G

Bordetella pertussis IgG Control Serum BC120G

Diphtheria IgG Control Serum BC130G

Aspergillus fumigatus IgG Control Serum BC132G

Adenovirus IgG Control Serum BC128G

Coxsackie IgA Virus Control Serum BC134A

Coxsackie IgM Virus Control Serum BC134M

Chlamydia trachomatis IgG Control Serum BC1372G

Chlamydia pneumoniae IgG Control Serum BC1371G

Candida albicans IgG Control Serum BC117G

Campylobacter jejuni IgG Control Serum BC139G